Table 2.

Comparison of metalloproteinases and cytokines between psoriatic patients and control group. ∗ indicates statistically significant differences.

Metalloproteinase or cytokine	Study group (N = 58)	Control group (N = 29)	p
Pro-MMP-1 (ng/mL)	7.75 ± 4.48	5.08 ± 3.47	0.006∗
Total MMP-3 (ng/mL)	17.52 ± 9.39	19.22 ± 7.08	0.391
MMP-9 (ng/mL)	1165.16 ± 472.93	903.08 ± 473.27	0.017∗
Pro-MMP-10 (pg/mL)	492.98 ± 229.46	554.76 ± 253.69	0.256
IL-12p70 (pg/mL)	1.01 ± 1.65	0.92 ± 1.43	0.822
IL-17A (pg/mL)	4.83 ± 6.75	3.2 ± 5.11	0.256
IL-2 (pg/mL)	18.87 ± 20.41	13.72 ± 18.29	0.255
IL-22 (pg/mL)	169.28 ± 65.74	163.46 ± 98.60	0.744
IL-6 (pg/mL)	1.41 ± 1.55	0.79 ± 0.99	0.050∗
IL-4 (pg/mL)	1.26 ± 2.69	0.93 ± 1.95	0.560
IL-5 (pg/mL)	1.72 ± 2.69	1.49 ± 2.62	0.700
IL-1beta (pg/mL)	14.35 ± 26.95	25.41 ± 39.85	0.130
TNF-α (pg/mL)	6.35 ± 6.72	7.36 ± 7.95	0.535